Works matching IS 20457634 AND DT 2023 AND VI 12 AND IP 4

Results: 109
    1
    2
    3
    4
    5

    Health‐related quality‐of‐life analyses from a multicenter, randomized, double‐blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4332, doi. 10.1002/cam4.5308
    By:
    • Taylor, Matthew H.;
    • Leboulleux, Sophie;
    • Panaseykin, Yury;
    • Konda, Bhavana;
    • de La Fouchardiere, Christelle;
    • Hughes, Brett G. M.;
    • Gianoukakis, Andrew G.;
    • Park, Young Joo;
    • Romanov, Ilia;
    • Krzyzanowska, Monika K.;
    • Garbinsky, Diana;
    • Sherif, Bintu;
    • Pan, Jie Janice;
    • Binder, Terri A.;
    • Sauter, Nicholas;
    • Xie, Ran;
    • Brose, Marcia S.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4306, doi. 10.1002/cam4.5301
    By:
    • Acosta‐Vega, Natalia L.;
    • Varela, Rodolfo;
    • Mesa, Jorge Andrés;
    • Garai, Jone;
    • Baddoo, Melody C.;
    • Gómez‐Gutiérrez, Alberto;
    • Serrano‐Gómez, Silvia J.;
    • Lemus, Marcela Nuñez;
    • Serrano, Martha Lucía;
    • Zabaleta, Jovanny;
    • Combita, Alba L.;
    • Sanabria‐Salas, María Carolina
    Publication type:
    Article
    12
    13
    14

    Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4282, doi. 10.1002/cam4.5298
    By:
    • Thirasastr, Prapassorn;
    • Lin, Heather;
    • Amini, Behrang;
    • Wang, Wei‐Lien;
    • Cloutier, Jeffrey M.;
    • Nassif, Elise F.;
    • Keung, Emily Z.;
    • Roland, Christina L.;
    • Feig, Barry;
    • Araujo, Dejka;
    • Benjamin, Robert S.;
    • Conley, Anthony P.;
    • Livingston, John A.;
    • Ludwig, Joseph;
    • Patel, Shreyaskumar;
    • Ratan, Ravin;
    • Ravi, Vinod;
    • Zarzour, Maria Alejandra;
    • Zhou, Xiao;
    • Somaiah, Neeta
    Publication type:
    Article
    15

    A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4270, doi. 10.1002/cam4.5297
    By:
    • Metts, Jonathan L.;
    • Trucco, Matteo;
    • Weiser, Daniel A.;
    • Thompson, Patrick;
    • Sandler, Eric;
    • Smith, Tiffany;
    • Crimella, Jessica;
    • Sansil, Samer;
    • Thapa, Ram;
    • Fridley, Brooke L.;
    • Llosa, Nicholas;
    • Badgett, Thomas;
    • Gorlick, Richard;
    • Reed, Damon;
    • Gill, Jonathan
    Publication type:
    Article
    16
    17

    Protein and amino acid intakes in relation to prostate cancer risk and mortality—A prospective study in the European Prospective Investigation into Cancer and Nutrition.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4725, doi. 10.1002/cam4.5289
    By:
    • Schmidt, Julie A.;
    • Huybrechts, Inge;
    • Overvad, Kim;
    • Eriksen, Anne Kirstine;
    • Tjønneland, Anne;
    • Kaaks, Rudolf;
    • Katzke, Verena;
    • Schulze, Matthias B.;
    • Pala, Valeria;
    • Sacerdote, Carlotta;
    • Tumino, Rosario;
    • Bueno‐de‐Mesquita, Bas;
    • Sánchez, Maria‐Jose;
    • Huerta, José M.;
    • Barricarte, Aurelio;
    • Amiano, Pilar;
    • Agudo, Antonio;
    • Bjartell, Anders;
    • Stocks, Tanja;
    • Thysell, Elin
    Publication type:
    Article
    18
    19

    The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
    By:
    • Hatanaka, Takeshi;
    • Naganuma, Atsushi;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Shimada, Noritomo
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4137, doi. 10.1002/cam4.5273
    By:
    • Shi, Guo‐Ming;
    • Huang, Xiao‐Yong;
    • Wen, Tian‐Fu;
    • Song, Tian‐Qiang;
    • Kuang, Ming;
    • Mou, Hai‐Bo;
    • Bao, Le‐Qun;
    • Zhao, Hai‐Tao;
    • Zhao, Hong;
    • Feng, Xie‐Lin;
    • Zhang, Bi‐Xiang;
    • Peng, Tao;
    • Zhang, Yu‐Bao;
    • Li, Xiang‐Cheng;
    • Yu, Hong‐Sheng;
    • Cao, Yu;
    • Liu, Lian‐Xin;
    • Zhang, Ti;
    • Wang, Wei‐Lin;
    • Ran, Jiang‐Hua
    Publication type:
    Article
    38
    39
    40
    41
    42

    Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4100, doi. 10.1002/cam4.5268
    By:
    • Sobu, Ryuta;
    • Numakura, Kazuyuki;
    • Naito, Sei;
    • Hatakeyama, Shingo;
    • Kato, Renpei;
    • Koguchi, Tomoyuki;
    • Kojima, Takahiro;
    • Kawasaki, Yoshihide;
    • Kandori, Syuya;
    • Kawamura, Sadafumi;
    • Arai, Yoichi;
    • Ito, Akihiro;
    • Nishiyama, Hiroyuki;
    • Kojima, Yoshiyuki;
    • Obara, Wataru;
    • Ohyama, Chikara;
    • Tsuchiya, Norihiko;
    • Habuchi, Tomonori
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50